-
Law Offices of Howard G. Smith Announces Class Action Lawsuit Against GPC Biotech
-
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Bioenvision, Inc.
-
Ardea Biosciences, Inc. Stockholders Approve Company Proposals at July 27, 2007 Annual Meeting
-
Biodel Inc. Plans Relocation to New Headquarters within Danbury, CT
-
ISTA Pharmaceuticals Announces Conference Call and Webcast of Second Quarter 2007 Financial Results
-
Clinical Trial Agreements & Budgets Forum, September 30 - October 3, San Diego
-
OmniGuide Announces CE Mark Approval of Flexible CO2 Laser Fibers
-
Heart Response Under Extreme Conditions - Signalife Technology Featured on CBC
-
Oncolytics Biotech Inc. Announces 2007 Second Quarter Results
-
AspenBio Pharma Advances BoviPure FSH(TM) Reproduction Drug with FDA Filing and GMP Manufacturing Contract
-
Radiation Therapy Services to Report Second Quarter 2007 Financial Results on August 2, 2007
-
Genaera Corporation Presents New Preclinical Data for Obesity Compound Trodusquemine (MSI-1436) at CBI Conference
-
Shire's New ADHD Medication, VYVANSE(TM) (lisdexamfetamine dimesylate) Now Available in U.S. Pharmacies Nationwide
-
China Sky One Medical Announces Clinical Trial of Eight New Products
-
Marketing Authorization Application for Satraplatin Accepted for Review by the European Medicines Agency
-
Mirus Bio Announces Delivery Technology Breakthrough for RNAi Therapeutics
-
Shire's New ADHD medication, VYVANSE(TM) (lisdexamfetamine dimesylate) Now Available in U.S. Pharmacies Nationwide
-
URAC Honors Two Leaders in Development of Nation's First Pharmacy Benefit Management Accreditation Program
-
MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 3, 2007
-
KV Pharmaceutical Announces Launch of Two Strengths of Generic Versions of Toprol-XL(R)
-
Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2007 Financial Results
-
Neogen Announces 3-for-2 Stock Split
-
Anesiva Announces Second Quarter 2007 Financial Results
-
QIAGEN Completes Exchange Offer for Digene Corporation
-
Monogram Announces Second Quarter 2007 Financial Results
-
Abbey Spanier Rodd & Abrams, LLP Commences Class Action Securities Fraud on Behalf of Purchasers of Securities
-
Faster, Easier Quantification of Secreted IgG Antibodies
-
Digital Healthcare Introduces Retasure in Asheville, NC
-
Health Coalition Calls on Pharma to Disclose Educational and Charitable Funding
-
AMDL Receives $261,600 From Directors' Exercise of Expiring Options
-
Thoratec Schedules Second Quarter Conference Call, Webcast
-
Cardinal Health Introduces New Offerings to Help Independent Retail Pharmacies Maximize Revenue, Extend Patient Care
-
Saatchi & Saatchi Healthcare Communications Goes Green
-
Phlo Affiliate Reports Rapid Account Growth
-
Dermatologists and Pathologists Assemble for In-Depth Training on Confocal Diagnostic Imaging Interpretation
-
Vanda Pharmaceuticals to Announce Second Quarter 2007 Financial Results on August 2, 2007
-
Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor
-
Ardea Biosciences, Inc. Announces Appointment of Patrick M. O'Connor as Senior Vice President of Research and Preclinical Development and Chief Scientific Officer
-
Illinois Neurological Institute at Saint Francis Medical Center Upgrades to Leksell Gamma Knife(R) Perfexion(TM)
-
West Pharmaceutical Services, Inc. to Host 2007 Second Quarter Conference Call
-
Thermo Fisher Scientific Extends Reach in India with Addition of Leading Laboratory Chemicals Supplier
-
Intellect Neurosciences, Inc. Appoints Dr. Thomas M. Wisniewski, M.D. to its Clinical Advisory Board
-
Verenium Corporation to Announce Second Quarter and Mid-Year Financial Results
-
Sunesis Pharmaceuticals to Report Second Quarter 2007 Financial Results
-
Threshold Pharmaceuticals Initiates Phase 1 Clinical Trial Evaluating TH-302 in Patients With Solid Tumors
-
Anti-Tumor Activity and Pharmacokinetic Properties of NKTR-102 (PEG-irinotecan) to be Presented at Upcoming Oncology Meeting
-
Anti-Tumor Activity and Pharmacokinetic Properties of NKTR-102 (PEG-irinotecan) to be Presented at Upcoming Oncology Meeting
-
Shire plc: 2007 Guidance Upgraded as Revenue Growth Accelerates
-
Bristol-Myers Squibb Company Reports Financial Results for the Second Quarter and First Half of 2007
-
BioCryst Announces Realignment and Strengthening of the Company's Executive Management Team
|